1-3 of 3
Steven Goossens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia

Stien De Coninck, Juliette Roels, Béatrice Lintermans, Sara T’Sas, Tom Taghon, David J. Curtis, Tim Pieters, Steven Goossens, Pieter Van Vlierberghe
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2646–2649.
https://doi.org/10.1182/bloodadvances.2023011970
Published: 2024
Includes: Supplemental data
Journal Articles

Myb drives B-cell neoplasms and myeloid malignancies in vivo

Tim Pieters, André Almeida, Sara T'Sas, Kelly Lemeire, Tino Hochepied, Geert Berx, Alex Kentsis, Steven Goossens, Pieter Van Vlierberghe
Journal: Blood Advances
Blood Adv (2022) 6 (10): 2987–2991.
https://doi.org/10.1182/bloodadvances.2021005955
Published: 2022
Includes: Supplemental data
Journal Articles

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL

Clinical Trials & Observations
Alessandra Di Grande, Sofie Peirs, Paul D. Donovan, Maaike Van Trimpont, Julie Morscio, Beatrice Lintermans, Lindy Reunes, Niels Vandamme, Steven Goossens, Hien Anh Nguyen, Arnon Lavie, Richard B. Lock, Jochen H. M. Prehn, Pieter Van Vlierberghe, Triona Ní Chonghaile
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1963–1976.
https://doi.org/10.1182/bloodadvances.2021004177
Published: 2021
Includes: Supplemental data